Browsing Category
Pharma Industry News
4730 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Anixa Biosciences (NASDAQ: ANIX) moves forward as Phase 1 breast cancer vaccine data clear safety and immune hurdles
Anixa Biosciences’ breast cancer vaccine met Phase 1 safety and immune response targets. Find out how Keytruda combinations could transform care.
Can UPLIZNA transform gMG treatment? Amgen’s FDA win sets new benchmark for antibody-positive patients
Discover how Amgen’s UPLIZNA is redefining generalized myasthenia gravis treatment after FDA approval. Find out what this means for patients and investors.
Mazdutide phase 1b results from Innovent Biologics offer new hope for adolescent obesity in China
Find out how Innovent Biologics’ mazdutide trial could change adolescent obesity treatment in China—phase 3 launch is next.
Senores Pharmaceuticals (NSE: SENORES) launches Deferiprone Tablets in U.S. with Dr. Reddy’s Laboratories
Find out how Senores Pharmaceuticals Limited’s Deferiprone launch in the U.S. is reshaping its generics growth strategy. Read more for expert analysis!
Glenmark’s U.S. launch of Leucovorin Calcium for Injection: A strategic play in the generics arena
Find out how Glenmark Pharmaceuticals’ latest U.S. launch could reshape hospital generics in 2025. Will this move boost its global strategy?
Senhwa Biosciences strikes pivotal supply deal with BeOne Medicines for cold tumor breakthrough
Senhwa Biosciences and BeOne Medicines announce a global clinical trial to tackle cold tumors. Find out how this deal could change cancer immunotherapy.
BlinkRx collaboration positions Scienture’s Arbli for nationwide patient access in the $250+ million losartan market
Discover how Scienture and BlinkRx are expanding nationwide access to Arbli, the first FDA-approved liquid losartan, and what it means for the $250M hypertension market.
Kazia Therapeutics (NASDAQ: KZIA) unveils immune-boosting effects of paxalisib in advanced breast cancer at SABCS 2025
Find out how Kazia Therapeutics’ paxalisib is breaking new ground in breast cancer immunotherapy. Read the latest clinical insights from SABCS 2025.
EC clears €47m German aid for Vetter Pharma’s new manufacturing hub
EU approves €47m in German state aid for Vetter Pharma’s Saarlouis plant. Learn how this supports pharma jobs, injectables, and regional strategy.
Innovent Biologics launches clinical trial for IBI3011 to target gout and inflammatory diseases in China
Find out how Innovent Biologics is targeting unmet needs in gout with IBI3011, a first-in-class anti-IL-1RAP antibody now in clinical trials. Read more.